Chris G. Slatore, M.D.
- click here
Dr. Slatore is interested in the prevention, detection, treatment, and healthcare delivery for patients with tobacco-related lung diseases, chiefly lung cancer and chronic obstructive pulmonary disease (COPD). His research has focused on improving patient outcomes and innovate approaches to treatment in the area of lung cancer and chronic obstructive pulmonary disease. As the recipient of a VA HSR&D Career Development Award, he is currently investigating the role of patient-clinician communication in the lung cancer evaluation process. He is also the principal investigator on a research study evaluating cancer comorbid with mental illness. Through the application of health services and epidemiologic research methodologies, he hopes to improve healthcare quality for patients with tobacco-related lung diseases.Recent publications:Brasky TM, Baik CS, Slatore CG, Potter JD, White E. Non-steroidal Anti-inflammatory Drugs and Small Cell Lung Cancer Risk in the VITAL Study. Lung Cancer. 2012 Aug;77(2):260-264. PMID: 22608142 Slatore CG, Hansen L, Ganzini L, Press N, Osborne ML, Chesnutt MS, Mularski RA. Nurse Communication in the ICU: A Qualitative Analysis of Patient-Centered Care Domains. AJCC. In press for November 2012. Brasky TM, Baik CS, Slatore CG, Alvarado M, White E. Pre-diagnostic non-steroidal anti-inflammatory drug use and lung cancer survival in the VITAL study. J Thorac Oncol. In press.
Summary of Current Research
Special Interests:Hematology and Medical OncologyLung CancerPalliative Care